StemCell Therapy

Dublin, Aug. 24, 2020 (GLOBE NEWSWIRE) -- The "Global Gene Therapy Market (by Cell Type, Vector Type, Application, End-User & Region): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)" report has been added to ResearchAndMarkets.com's offering.

The global gene therapy market is expected to reach US$ 6.42 billion in 2024, witnessing growth at a CAGR of 19.29%, over the period 2020-2024.

Growth in the gene therapy market has accrued due to the increasing prevalence of chronic diseases, rising healthcare expenditure, expanding urbanization, growth of gene therapy clinical trials and upsurge in economic growth. The market is anticipated to experience certain trends like rapid adoption of personalized medicine, growing occurrence of genetic disorders, advancements in gene therapy and increasing R&D funding. The growth of the market would be challenged by side effects of gene therapy and ethical and safety concerns and high cost of the treatment.

The global gene therapy market has been segmented on the basis of cell type, vector type, application, end-user and region. Depending on the cell type, the market can be bifurcated into somatic cell gene therapy and germ cell gene therapy. According to the vector type, the global gene therapy market can be categorized into retrovirus & gammaretrovirus, adeno-associated viruses (AAV), lentivirus, adenovirus, modified herpes simplex virus and non-viral plasmid vector. Whereas, on the basis of application, the market can be split into oncological disorders, neurological disorders, infectious diseases, cardiovascular diseases, rare diseases and others. Further, in terms of end-user, the global gene therapy market can broadly be segmented into hospitals, specialty treatment centers and other end-users.

The fastest-growing regional market is North America due to the rising incidence of cancer and other target diseases, increasing favorable reimbursement scenario in the region and improvements in healthcare infrastructure. Further, the sudden outbreak of COVID-19 is causing an adverse disruption on the overall economy and society, affecting the rate of gene therapy procedures and clinical trials, which is expected to negatively impact the growth of the global gene therapy market during the forecasted period.

Scope of the report:

Key Topics Covered:

1. Market Overview

2. Impact of COVID-192.1 Economic Impact2.2 Decline in Global GDP2.3 Decline in Industrial Production2.4 Impact on Gene Therapy2.5 Impact on Clinical Trials of Gene Therapy

3. Global Market Analysis3.1 Global Gene Therapy Market by Value3.2 Global Gene Therapy Market Forecast by Value3.3 Global Gene Therapy Market by Cell Type3.3.1 Global Somatic Cell Gene Therapy Market by Value3.3.2 Global Somatic Cell Gene Therapy Market Forecast by Value3.3.3 Global Germ Cell Gene Therapy Market by Value3.3.4 Global Germ Cell Gene Therapy Market Forecast by Value3.4 Global Gene Therapy Market by Vector Type3.4.1 Global Retrovirus & Gammaretrovirus Gene Therapy Market by Value3.4.2 Global Retrovirus & Gammaretrovirus Gene Therapy Market Forecast by Value3.4.3 Global Adeno-Associated Viruses Gene Therapy Market by Value3.4.4 Global Adeno-Associated Viruses Gene Therapy Market Forecast by Value3.4.5 Global Lentivirus Gene Therapy Market by Value 3.4.6 Global Lentivirus Gene Therapy Market Forecast by Value3.4.7 Global Adenovirus Gene Therapy Market by Value3.4.8 Global Adenovirus Gene Therapy Market Forecast by Value3.4.9 Global Modified Herpes Simplex Virus Gene Therapy Market by Value 3.4.10 Global Modified Herpes Simplex Virus Gene Therapy Market Forecast by Value3.4.11 Global Non-Viral Plasmid Vector Gene Therapy Market by Value3.4.12 Global Non-Viral Plasmid Vector Gene Therapy Market Forecast by Value3.5 Global Gene Therapy Market by Application3.5.1 Global Oncological Disorders Gene Therapy Market by Value3.5.2 Global Oncological Disorders Gene Therapy Market Forecast by Value3.5.3 Global Neurological Disorders Gene Therapy Market by Value3.5.4 Global Neurological Disorders Gene Therapy Market Forecast by Value3.5.5 Global Infectious Disease Gene Therapy Market by Value3.5.6 Global Infectious Disease Gene Therapy Market Forecast by Value3.5.7 Global Cardiovascular Diseases Gene Therapy Market by Value3.5.8 Global Cardiovascular Diseases Gene Therapy Market Forecast by Value3.5.9 Global Rare Diseases Gene Therapy Market by Value 3.5.10 Global Rare Diseases Gene Therapy Market Forecast by Value3.6 Global Gene Therapy Market by End-User3.6.1 Global Hospitals & Clinics Gene Therapy Market by Value3.6.2 Global Hospitals & Clinics Gene Therapy Market Forecast by Value3.6.3 Global Specialty Treatment Centers Gene Therapy Market by Value3.6.4 Global Specialty Treatment Centers Gene Therapy Market Forecast by Value3.7 Global Gene Therapy Market by Region

4. Regional Market Analysis4.1 North America4.1.1 North America Gene Therapy Market by Value4.1.2 North America Gene Therapy Market Forecast by Value4.2 Europe4.2.1 Europe Gene Therapy Market by Value4.2.2 Europe Gene Therapy Market Forecast by Value4.2.3 Europe Gene Therapy Market by Indication4.2.4 Europe Large B-Cell Lymphoma Gene Therapy Market by Value4.2.5 Europe Large B-Cell Lymphoma Gene Therapy Market Forecast by Value4.2.6 Europe Inherited Retinal Disease Gene Therapy Market by Value4.2.7 Europe Inherited Retinal Disease Gene Therapy Market Forecast by Value4.2.8 Europe ADA-SCID Gene Therapy Market by Value4.2.9 Europe ADA-SCID Gene Therapy Market Forecast by Value4.2.10 Europe Acute Lymphoblastic Leukemia Gene Therapy Market by Value4.2.11 Europe Acute Lymphoblastic Leukemia Gene Therapy Market Forecast by Value4.3 Asia Pacific4.3.1 Asia Pacific Gene Therapy Market by Value4.3.2 Asia Pacific Gene Therapy Market Forecast by Value4.4 RoW4.4.1 RoW Gene Therapy Market by Value4.4.2 RoW Gene Therapy Market Forecast by Value

5. Market Dynamics5.1 Growth Drivers5.1.1 Increasing Prevalence of Chronic Diseases5.1.2 Rising Healthcare Expenditure5.1.3 Expanding Urbanization 5.1.4 Growth of Gene Therapy Clinical Trials5.1.5 Upsurge in Economic Growth5.2 Key Trends and Developments5.2.1 Rapid Adoption of Personalized Medicines5.2.2 Growing Occurrence of Genetic Disorders5.2.3 Advancements in Gene Therapy5.2.4 Increasing R&D Funding5.3 Challenges5.3.1 Side Effects of Gene Therapy5.3.2 Ethical and Safety Concerns5.3.3 High Cost of Treatment

6. Competitive Landscape6.1 Global Market6.1.1 Revenue Comparison of Key Players6.1.2 Market Capitalization Comparison of Key Players6.1.3 R&D Comparison of Key Players

7. Company Profiles7.1 Roche Holding AG7.1.1 Business Overview7.1.2 Financial Overview7.1.3 Business Strategies7.2 Pfizer Inc.7.2.1 Business Overview7.2.2 Financial Overview7.2.3 Business Strategies7.3 Novartis International AG7.3.1 Business Overview7.3.2 Financial Overview7.3.3 Business Strategies7.4 GlaxoSmithKline PLC7.4.1 Business Overview7.4.2 Financial Overview7.4.3 Business Strategies7.5 Bristol Myers Squibb Co. (Celgene Corporation)7.5.1 Business Overview7.5.2 Financial Overview7.5.3 Business Strategies7.6 Gilead Sciences, Inc.7.6.1 Business Overview7.6.2 Financial Overview7.6.3 Business Strategies

For more information about this report visit https://www.researchandmarkets.com/r/gjuirj

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Read the original:
Outlook on the Worldwide Gene Therapy Industry to 2024 - Insights & Forecast with Potential Impact of COVID-19 - GlobeNewswire

This entry was posted on August 24, 2020 at 9:56 pm and is filed under Gene therapy. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |